70 237

Cited 0 times in

IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy.

Authors
Lee, HC; Lee, KW; Chung, CH; Chung, YS; Lee, EJ; Lim, SK; Kim, KR; Huh, KB; Lee, SC; Kwon, OW
Citation
Diabetes research and clinical practice, 24(2):85-88, 1994
Journal Title
Diabetes research and clinical practice
ISSN
0168-82271872-8227
Abstract
Vitreous fluid and serum were obtained at the time of vitrectomy from 15 subjects with diabetic proliferative retinopathy and 6 control subjects. The mean serum IGF-I (IGF-I level: 1 nM/l = 7.7 ng/ml) concentrations were 15.40 +/- 4.97 nM/l in controls and 16.24 +/- 4.32 nM/l in diabetic patients. The mean vitreous IGF-I concentration was 1.05 +/- 0.30 nM/l in controls and 0.91 +/- 0.50 nM/l in diabetic patients. There were no significant differences between the two groups, and serum IGF-I concentrations were not correlated with vitreous IGF-I concentrations in the patients with diabetic proliferative retinopathy. These data suggest that IGF-I may not be a risk factor for the development of proliferative diabetic retinpathy.
MeSH terms
AdultAgedBlood PressureDiabetic Retinopathy/blood/*physiopathology/surgeryHumansInsulin-Like Growth Factor I/analysis/*metabolismMiddle AgedRadioimmunoassayReference ValuesVitrectomyVitreous Body/*chemistry
PMID
7956713
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Endocrinology & Metabolism
AJOU Authors
정, 윤석
Files in This Item:
fulltext not available.txtDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse